Literature DB >> 19107975

Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior.

Alicia C McDonald1, Camille C Ragin, Frank J Jenkins, Joel Weissfeld, John Wilson, Victor W Wheeler, Jaquie B Wilson, Clareann H Bunker, Emanuela Taioli.   

Abstract

Human herpesvirus 8 (HHV-8) infection is present in 22.9% of Tobago men. However, seroprevalence and modes of transmission of HHV-8 among Tobago women are not known. HHV-8 seropositivity rates in Tobago women were examined and compared rates to Tobago men of similar ages. To assess possible modes of transmission, sexual behavior among Tobago women was examined to determine its association with HHV-8 seropositivity. A cross-sectional study was conducted in 213 Tobago women, ages 18-65 years, who participated in the Tobago Cervical and Oral Cancer Screening Study. HHV-8 seropositivity was determined by a monoclonal immunofluorescence assay. Age-specific rates were compared to those previously observed in men. Logistic regression analyses were performed to determine the association between HHV-8 seropositivity and sexual behavior among the women. HHV-8 seroprevalence among Tobago women was 14.1% (95% CI, 10-19%), with no significant difference with men of similar age (P-value = 0.741). Age <or=17 years at first sexual intercourse was found to have a minimal significant association with HHV-8 seropositivity (OR = 2.51, 95% CI = 1.09-5.78) in women. HHV-8 age-specific rates were similar between genders. Sexual activity may not be a major contributor to HHV-8 infection among Tobago women. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19107975      PMCID: PMC2851225          DOI: 10.1002/jmv.21346

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  40 in total

1.  Risk of transfusion-associated transmission of human herpesvirus 8.

Authors:  E A Engels; H Eastman; D V Ablashi; R J Wilks; J Braham; A Manns
Journal:  J Natl Cancer Inst       Date:  1999-10-20       Impact factor: 13.506

2.  Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia.

Authors:  D Serraino; D Cerimele; P Piselli; L Aztori; F Farchi; F Carletti; A Navarra; M V Masala; G Rezza
Journal:  Infection       Date:  2006-02       Impact factor: 3.553

3.  Antibodies against human herpesvirus 8 in subjects with non-venereal dermatological conditions.

Authors:  C Masini; D D Abeni; M S Cattaruzza; M Capuano; C Pedicelli; F Cerimele; P Pasquini; D Cerimele; G Fadda; P Cattani
Journal:  Br J Dermatol       Date:  2000-09       Impact factor: 9.302

4.  Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon.

Authors:  G Rezza; O B Tchangmena; M Andreoni; R Bugarini; L Toma; D K Bakary; M Glikoutou; L Sarmati; P Monini; P Pezzotti; B Ensoli
Journal:  Sex Transm Dis       Date:  2000-03       Impact factor: 2.830

5.  Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.

Authors:  Elisa Martró; Anna Esteve; Thomas F Schulz; Julie Sheldon; Gemma Gambús; Rafael Muñoz; Denise Whitby; Jordi Casabona
Journal:  Int J Cancer       Date:  2007-03-01       Impact factor: 7.396

6.  Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.

Authors:  Eric A Engels; Jonnae O Atkinson; Barry I Graubard; Geraldine M McQuillan; Christine Gamache; Georgina Mbisa; Silvia Cohn; Denise Whitby; James J Goedert
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

Review 7.  Transmission of human herpesvirus 8: an update.

Authors:  Francesca Pica; Antonio Volpi
Journal:  Curr Opin Infect Dis       Date:  2007-04       Impact factor: 4.915

8.  Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count.

Authors:  M Gandhi; D M Koelle; N Ameli; P Bacchetti; J S Greenspan; M Navazesh; K Anastos; R M Greenblatt
Journal:  J Dent Res       Date:  2004-08       Impact factor: 6.116

9.  Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago.

Authors:  C C R Ragin; V W Wheeler; J B Wilson; C H Bunker; S M Gollin; A L Patrick; E Taioli
Journal:  Biomarkers       Date:  2007 Sep-Oct       Impact factor: 2.658

10.  Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa.

Authors:  D Ablashi; L Chatlynne; H Cooper; D Thomas; M Yadav; A W Norhanom; A K Chandana; V Churdboonchart; S A Kulpradist; M Patnaik; K Liegmann; R Masood; M Reitz; F Cleghorn; A Manns; P H Levine; C Rabkin; R Biggar; F Jensen; P Gill; N Jack; J Edwards; J Whitman; C Boshoff
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

View more
  2 in total

1.  Do fewer cases of Kaposi's sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence?

Authors:  Claudia Reinheimer; Regina Allwinn; Martin Stürmer
Journal:  Med Microbiol Immunol       Date:  2011-02-19       Impact factor: 3.402

2.  A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago.

Authors:  Alicia C McDonald; Frank J Jenkins; Clareann H Bunker; John W Wilson; Alan L Patrick; Joel L Weissfeld
Journal:  Infect Agent Cancer       Date:  2011-12-07       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.